facebook

ALFAccurate AAA Budding Beasts

Scheme Rating

IME Scheme Rating

5 of 5 stars

Good Mid and Small Option: ALFaccurate is a strong option for investors looking at mid and small-cap specific strategies, primarily due to the strength of their core investment team, their lower-risk investment approach (diversification & risk controls) and the proven track record of their longer-running strategies.

IME Strategy Rating

4 of 5 stars

Strong Rationale for Mid and Small Cap Strategy with proven Execution capabilities of AMC’s 3M Framework: Strong investment philosophy and rationale for mid and small-cap exposure. The investment team at ALFaccurate established strong execution capabilities of their 3M investment framework (focus on market size, the margin of safety and market share) over the past 10 years through various aged strategies. This diversified strategy is in line with ALFAccurate’s philosophy of running strong risk controls to provide superior risk-adjusted returns for investors, this has been followed consistently. A more diversified strategy does help reduce the high volatility & company risks inherent in mid & small-cap investing.

PMS Scheme Ratings are driven by IME’s Proprietary Scheme Rating Methodology, which takes into account our ratings of the Scheme’s investment strategy, its maturity, the investment team, and our separate rating on the AMC that runs this particular scheme. Our views on each of these individual criteria are available via the IME RMS – which you can view by reaching out to one of our relationship managers (using either the live chat or book appointment feature on this site).

IME View on ALFAccurate AAA Budding Beasts

Type: Mid & Smallcap | GARP | AUM (255.8 cr) | Inc Date (1 Jan 2021)

Investment Strategy

ALFaccurate AAA Emerging Giants is a diversified predominantly small and mid-cap strategy. It intends to invest in 30-60 companies which are market leaders with strong corporate governance and high growth potential with 3-5 years investment horizon.

The strategy aims to benefit from the strong beneficiaries of mid and small-cap on the back of a strong economic recovery post covid impact.

  • Play Sectoral Leaders: invest in small-cap companies with large profit sizes with a current leadership position in the sector
  • Significant Growth Opportunity: on the back of a strong economic recovery, small and mid-cap companies can lead to superior returns due to high growth opportunities
  • Value Identification: Alfaccurate has a proven track record of identifying multibaggers

Investment Philosophy

ALFAccurate PMS follows a 3M Investment Approach, by focusing on the Market size, Margin of safety, and Market Share backed by ‘Right Balance Sheet’, ‘Right Management’, and ‘Right Governance’. In essence, ALFAccurate follows a GARP philosophy (growth at a reasonable price). 

  • Market Size: Identify large opportunities for the companies to capture
  • Market Share: Identify leaders in the sectors
  • Margin of Safety: Buy companies at a reasonable valuation with the above-mentioned criteria.

Portfolio Construction and Risk Management

ALFAccurate AAA Focus Plan invests in up to 30 companies. The strategy also has a clearly articulated risk management framework:

  • Mid/small-cap exposure: 65-100%
  • Large-cap exposure: 0-35%
  • Max weightage in one stock: 10%
  • Max weightage in one sector: 30%
  • Max weightage in top-10 stocks: 50%

Trailing Performance

1yr 3yr 5yr Since Inception
ALFAccurate AAA Budding Beasts 48.2 30.6 31
S&P BSE 500 TRI 39.5 19.5 20.6
Alpha over Broad Mkt BM 8.7 11.1 10.4
Nifty Midcap 150 56.3 26.5
Alpha over Category BM -8.1 4.1

Performance as of: 28-Feb-23 | Inception Date: 01-Jan-21

Fund Managers

Rajesh Kothari | 5-star rated FM

CIO | 27 yrs Experience | 15 yrs at current firm

Past Experience: Voyager (FM), DSP ML (FM)

Rajesh is the founder of AlfAccurate Advisors, which he set up in 2009, after a strong track record in equity fund management at DSP ML & Voyager. During his tenure at DSP ML, the AUM increased from $100 mn to $1.5 bn and the funds he managed consistently ranked in the top quartile of performance.

Govind Agarwal | 4-star rated FM

Director | 30 yrs Experience | 10 yrs at current firm

Past Experience: Reliance MF (FM) / UBS Securities (Equity Sales) / Motilal Oswal (Equity Sales)

A seasoned equity professional, Govind has over 2 decades of equity experience across fund management and institutional equity sales at top AMCs (Reliance MF) and institutional equity brokerage firms (UBS, Motilal).

Fee Structure

Fee StructureFee
Fixed Fee Structure2.5
Variable Fee Structures1.5% fixed + 20% above 10% hurdle
Exit Fees1yr(2%)

AMC

AMC: ALFAccurate PMS (click link for detailed AMC review)

Highly recommended for more conservative investors: ALFAccurate PMS has a number of positives (a highly seasoned investment team, a long-term track record, founder-cum-manager, and a clearly defined and followed investment strategy) that make it a credible PMS provider. While they follow a more diversified strategy (more similar to MF's than the more concentrated strategies common with other PMS providers), their strategies are a good option for investors seeking more stable long-term returns.

AMC Rating

5 of 5 stars

AMC Pedigree

5 of 5 stars

AMC Size

4 of 5 stars

Team Pedigree

5 of 5 stars

Inv Philosophy

5 of 5 stars

Performance

5 of 5 stars

Get substantially greater insights by connecting with us!

Details shared on the public website, are only a short snapshot of the more detailed analysis that resides in our Proprietary Research Management Solution (RMS) – A proprietary cloud-based tool, that ensures that the unbiased research insights of our central research team are shared directly with investors.

Our RMS allows us to operate with a level of transparency, ethics & consistency of insights, that is unparrarelled in the industry. Our RM’s will help showcase the PMS/AIF options that are the most suited for your unique requirements.

Download Sample RMS Reports: AMC View | Scheme Comparison

Note: PMS AMC & Scheme Reviews and Ratings are based on IME Capital’s Proprietary Review and Rating Methodology (read more here: AMC Rating & Scheme Ratings). These reflect the unbiased views of our central research team, based on our assessment of the investment value of these PMS/AIF strategies for our investors. We follow a highly stringent rating-criteria, where approximately 50% of PMS AMC’s & strategies would be rated 2-star or below (this is not meant to indicate that these funds are not investment-worthy, but that they do not currently fulfill the requirements we focus on for recommending funds to our investors — based on our internal views on the merit of the AMC/strategy relative to peers). Reviews & Ratings are primarily based on research of publicly available information (SEBI disclosures, PMS websites, PMS-aggregation platforms, webinar recording, media interviews etc.) and no explicit consent is required from AMCs for the same. While we endeavour to do further due-diligence via direct interactions with the investment teams of AMCs, this is typically restricted to AMC’s that meet our foundational fund selection criteria (reviews on lower-rated AMCs are often based solely on publicly available information). The views reflected in our Reviews & Ratings, are our independent views and may not be shared by the AMC’s and the investment teams. Please read detailed disclaimer for more.